An observational study on risk of secondary cancers in chronic myeloid leukemia patients in the TKI era in the United States.

about

An observational study on risk of secondary cancers in chronic myeloid leukemia patients in the TKI era in the United States.

Item

http://www.wikidata.org/entity/Q49873738

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

An observational study on risk ...... TKI era in the United States.

@en

An observational study on risk ...... TKI era in the United States.

@nl

type

Item

label

An observational study on risk ...... TKI era in the United States.

@en

An observational study on risk ...... TKI era in the United States.

@nl

prefLabel

An observational study on risk ...... TKI era in the United States.

@en

An observational study on risk ...... TKI era in the United States.

@nl

P1476

An observational study on risk ...... TKI era in the United States.

@en

P2093

Mohit Garg

http://www.w3.org/2001/XMLSchema#string

Neha Chaudhary

http://www.w3.org/2001/XMLSchema#string

P2860

Multicenter Independent Assessment of Outcomes in Chronic Myeloid Leukemia Patients Treated With Imatinib

Comparison of SEER Treatment Data With Medicare Claims.

Allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia in Europe 2006: transplant activity, long-term data and current results. An analysis by the Chronic Leukemia Working Party of the European Group for Blood and Marrow Tra

Relapse and late mortality in 5-year survivors of myeloablative allogeneic hematopoietic cell transplantation for chronic myeloid leukemia in first chronic phase.

Secondary solid cancers after allogeneic hematopoietic cell transplantation using busulfan-cyclophosphamide conditioning.

Second primary malignancies in chronic myeloid leukemia.

Occurrence of secondary malignancies in chronic myeloid leukemia during therapy with imatinib mesylate-single institution experience.

Chronic myelogenous leukemia: role of stem cell transplant in the imatinib era.

Malignancies occurring during therapy with tyrosine kinase inhibitors (TKIs) for chronic myeloid leukemia (CML) and other hematologic malignancies.

Chronic lymphocytic leukemia developing in a patient with chronic myeloid leukemia: evidence of distinct lineage-associated genomic events.

P304

e4342

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.7717/PEERJ.4342

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Abhinav B. Chandra

Vivek Kumar

P577

2018-02-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29456888

http://www.w3.org/2001/XMLSchema#string

P921

leukemia

chronic myeloid leukemia

P932

5813591

http://www.w3.org/2001/XMLSchema#string